|
|
Sequenom Incorporated - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Sequenom Incorporated. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Sequenom Incorporated. The Group's principal activity is providing genetic analysis products that translate genomic science into superior solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. The Group's proprietary MassARRAY(R) system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. It has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY(R) system and other platforms. It operates in the United States, Germany, United Kingdom, Japan, Hong Kong and India.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|